TARRICONE, ROSANNA
 Distribuzione geografica
Continente #
EU - Europa 15.179
NA - Nord America 7.447
AS - Asia 2.490
AF - Africa 87
SA - Sud America 58
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 43
Totale 25.359
Nazione #
IT - Italia 8.912
US - Stati Uniti d'America 6.986
IE - Irlanda 1.813
GB - Regno Unito 1.284
UA - Ucraina 923
CN - Cina 901
SE - Svezia 477
DE - Germania 433
CA - Canada 425
TR - Turchia 397
FI - Finlandia 305
VN - Vietnam 280
FR - Francia 276
SG - Singapore 256
HK - Hong Kong 156
IN - India 144
BG - Bulgaria 137
KR - Corea 127
BE - Belgio 92
CZ - Repubblica Ceca 78
RU - Federazione Russa 59
NL - Olanda 52
CH - Svizzera 51
KZ - Kazakistan 48
AU - Australia 46
DK - Danimarca 43
ES - Italia 40
EU - Europa 40
IR - Iran 30
GR - Grecia 28
PT - Portogallo 28
JP - Giappone 27
RO - Romania 27
BR - Brasile 25
PL - Polonia 25
TH - Thailandia 24
AL - Albania 23
AT - Austria 20
MX - Messico 20
ZA - Sudafrica 16
MA - Marocco 15
EG - Egitto 14
JO - Giordania 13
TN - Tunisia 12
PH - Filippine 11
CO - Colombia 10
ID - Indonesia 10
TW - Taiwan 10
NZ - Nuova Zelanda 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
AR - Argentina 7
LT - Lituania 7
CL - Cile 6
IL - Israele 6
IQ - Iraq 6
LV - Lettonia 6
NO - Norvegia 6
MU - Mauritius 5
NI - Nicaragua 5
PA - Panama 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
BY - Bielorussia 4
EC - Ecuador 4
NG - Nigeria 4
PK - Pakistan 4
SM - San Marino 4
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
GH - Ghana 3
HU - Ungheria 3
KE - Kenya 3
LU - Lussemburgo 3
MT - Malta 3
MW - Malawi 3
SA - Arabia Saudita 3
SI - Slovenia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
GE - Georgia 2
GG - Guernsey 2
HN - Honduras 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MC - Monaco 2
MD - Moldavia 2
SD - Sudan 2
TJ - Tagikistan 2
A1 - Anonimo 1
AD - Andorra 1
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BZ - Belize 1
CD - Congo 1
CM - Camerun 1
Totale 25.351
Città #
Dublin 1.800
Milan 1.331
Chandler 1.161
Jacksonville 749
Rome 745
Southend 628
Ann Arbor 522
Toronto 379
Dearborn 337
Dong Ket 237
New York 237
Beijing 233
Houston 224
Wilmington 214
Lawrence 183
Helsinki 170
Ashburn 168
Izmir 163
Boston 161
Boardman 158
Modena 150
Singapore 144
Turin 140
Redmond 139
Hong Kong 137
Mountain View 124
Redwood City 121
Seoul 121
Naples 120
Bologna 111
Woodbridge 88
Florence 87
Bari 74
Brussels 74
Fairfield 62
Seattle 60
Catania 59
Hefei 53
Genoa 51
Palombara Sabina 50
Padova 48
Almaty 47
Napoli 46
Nanjing 44
Los Angeles 43
Falls Church 42
Kunming 40
Palermo 40
Trieste 35
Duncan 34
London 33
Brescia 32
Munich 31
Perugia 31
Dallas 30
Saint Petersburg 30
Torino 30
Pisa 28
Brno 27
Pescara 27
Taranto 27
Washington 27
Fremont 26
Jinan 26
Cagliari 25
Guangzhou 25
Livorno 25
Paris 25
Messina 24
Monza 24
Trento 23
Verona 23
Bergamo 22
Genova 22
Norwalk 22
Latina 21
Treviso 21
Udine 20
Ancona 19
Pavia 19
Venezia 19
Forlì 18
Frankfurt am Main 18
Lucca 18
Sassari 18
Lisbon 17
Robbiate 17
Sabbioneta 17
Antalya 16
Athens 16
Busto Arsizio 16
Dalmine 16
Nanchang 16
Nardò 16
Salerno 16
San Mateo 16
Venice 16
Auburn Hills 15
Bonndorf 15
Novara 15
Totale 13.280
Nome #
Analisi dei costi della procedura angioplastica coronarica per via transradiale in regime ambulatoriale in Italia 3.430
Misurare le performance per creare valore nelle aziende sanitarie pubbliche: uno strumento multidimensionale di valutazione 1.947
Economic Evaluation for Devices and Drugs-Same or Different? 455
Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study 409
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato? 304
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 286
Impatto economico dell'utilizzo di carbossimaltosio ferrico in pazienti con anemia di carenza di ferro nelle regioni italiane 267
Esiti di salute e performance del Servizio Sanitario Nazionale 262
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 253
Innovazione e competitività nei sistemi industriali regolati : le imprese dei dispositivi medici 246
Valutazioni economiche e management in sanità. Applicazioni ai programmi e tecnologie sanitarie 241
Metodologia di indagine e primi risultati sul costo sociale della depressione maggiore in Italia 238
Lo sviluppo dell'Health Technology Assessment in Italia: contenuti, approcci e riferimenti internazionali 235
Il miglioramento del performance management nelle aziende sanitarie pubbliche: oltre le mode e le tradizioni 227
Basic principles of health technology assessment, economic evaluation, and costing of healthcare programs 214
I dispositivi medici in Italia: un settore, tanti mercati 212
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 211
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione? 194
Initiatives to improve control, resource use, and quality of life associated with chemotherapy-induced nausea and vomiting 186
Le imprese produttrici di dispositivi medici e le caratteristiche del prodotto e del mercato 175
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 172
Economic evaluation of medical devices 170
Impatto del sistema di finanziamento a DRG sull’innovazione tecnologica in sanità. Il caso italiano 167
Gli esiti di salute del Servizio Sanitario Nazionale 166
Approccio value-based e logiche di finanziamento: implicazioni per le politiche di rimborsabilità in sanità 157
Public Versus Private Financing 156
Tempi di attesa: trend e politiche di risposta durante e dopo la crisi Covid-19 155
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 154
Current and Future Trends in the HTA of Medical Devices 152
Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis 152
Il governo dell’innovazione tecnologica in sanità. Il caso dell’impianto di valvola aortica transcatetere: stato dell’arte delle indicazioni e della rimborsabilità nelle regioni italiane 148
Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation 148
Gli esiti di salute del Servizio Sanitario Nazionale 146
The impact of HTA and procurement practices on the selection and prices of medical devices 144
Myth #5: health care is rightly left to the private sector, for the sake of efficiency 143
Il costo sociale della schizofrenia. Una rassegna ragionata della bibliografia 138
Diffusion without evidence: a study on high-risk medical devices 135
Learning effect and diffusion of innovative medical devices: the case of transcatheter aortic valve implantation in Italy 131
Do social values and institutional context shape the use of economic evaluation in reimbursement decisions? An empirical analysis 131
Sustainability of Universal Health Coverage: Five Continents, Four Perspectives 129
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia 129
The Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer 129
Challenges in the assessment of medical devices: the MedtecHTA Project 125
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 122
Key reccomendations from the MedtecHTA project 122
Integrating HTA principles into procurement of medical devices: the Italian national HTA programme for medical devices 122
Direct costs of intracranial aneurysm treatment in the Italian hospitals 121
The evolution of the Italian National Health Service 120
L'adozione dell'innovazione tecnologica da parte degli ospedali italiani: un'analisi dei fattori endogeni 119
Does the approach to economic evaluation in health care depend on culture, values, and institutional context? 119
Valutazione di Health Technology Assessment del sistema di sanificazione biologico a base di probiotici del genere Bacillus (PCHS) 118
Comparative effectiveness of Mitraclip plus medical therapy versus medical therapy alone in high-risk surgical patients: a comprehensive review 118
Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project 118
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses 116
Improving the methods for the economic evaluation of medical devices 115
Analisi costi-efficacia della cura del dolore in Italia: la radioisotopoterapia con Samario-153 e la terapia convenzionale 114
Comparing drug and non-drug technologies in comparative effectiveness research 109
I costi ospedalieri dell'ictus in Italia: un confronto tra diversi modelli di cura 108
Valutazione economica della prevenzione con misoprostol della gastropatia da farmaci anti-infiammatori non steoridei in italia 108
Valutare l’impatto dell’HTA come strumento di governo dell’innovazione tecnologica: modelli teorici e studi empirici 108
Measuring value in health care: a comparative analysis of value-based frameworks 108
Planning and control of medical device investments by Italian public health authorities: a means to improve the decision-making process 107
Influence of sanitizing methods on healthcare-associated infections onset: a multicentre, randomized, controlled pre-post interventional study. 107
Core outcome set in surgical oncology: why, what and how to measure 107
An economic perspective on urinary tract infection: the "costs of resignation" 105
Economic evidence of interventions for acute myocardial infarction: a review of the literature 104
Costing and performance in healthcare management 104
Analisi costi-efficacia della cura del dolore in Italia: la radioisotopoterapia con Samario-153 e la terapia convenzionale 103
Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review 103
Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the “Italian Hernia Club” registry 103
Cost–effectiveness analysis of treatments involving radioembolization in intermediate-stage hepatocellular carcinoma 102
Controllo delle infezioni ospedaliere attraverso un sistema di sanificazione a base di probiotici: valutazione clinica ed economica 102
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 101
Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis 100
Should health technology assessment be more patient centric? If so, how? 100
Mobile health divide between clinicians and patients in cancer care: results from a cross-sectional international survey 100
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems? 100
Harmonization of health technology assessment across the European Union: lessons for the United States 100
Budget impact analysis of a biosynthetic mesh for incisional hernia repair 99
What type of clinical evidence is needed to assess medical devices? 99
Cost-benefit analysis in health care: the case of bariatric surgery compared with diet 99
Distinguishing features in the assessment of mHealth apps 99
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis 99
Applying Health Economics for Policy Decision Making: Do Devices Differ From Drugs? 98
European diabetes research and its funding, 2002–2013 98
Assessing the added value of health technologies: reconciling different perspectives 97
Cost-effectiveness for trigeminal neuralgia: Cyberknife vs microvascular decompression 96
Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analyses 96
Genetic Screening for the Predisposition to Venous Thromboembolism: A Cost-Utility Analysis of Clinical Practice in the Italian HealthCare System 96
Terapia dell'ictus: valutazione economica e modelli organizzativi 96
Challenges in the clinical and economic evaluation of medical devices: the case of transcathether aortic valve implantation 95
Prefazione 95
Il sistema assicurativo sanitario olandese 94
COI analysis: what room in health economics? 94
The rise of rules: will the new regulation of medical devices make us safer? 94
Systematic review of urinary incontinence and overactive bladder cost-of-illness studies 94
Characterising uncertainty in the assessment of medical devices and determining future research needs 93
Direct and indirect costs of schizophrenia in community psychiatric services in Italy: The GISIES study 91
Valutazione economica dell’uso di Gas Plasma di perossido di idrogeno nella sterilizzazione in ambito ospedaliero 91
State-of-the-art of abdominal wall surgery in Italy: coding, reimbursement, hospitalisations and expenditure for surgical meshes 91
Totale 19.306
Categoria #
all - tutte 85.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.701 149 55 243 205 300 516 639 310 343 369 283 289
2020/20213.429 183 274 138 303 381 247 322 171 368 235 353 454
2021/20223.203 202 451 125 167 261 156 163 521 238 257 325 337
2022/20237.126 385 371 200 603 522 561 304 509 2.560 320 441 350
2023/20245.158 327 264 351 235 439 543 474 595 304 357 625 644
2024/2025271 271 0 0 0 0 0 0 0 0 0 0 0
Totale 25.895